摘要
目的观察普米克令舒联合万托林、爱全乐雾化吸入治疗慢性阻塞性肺疾病急性发作的疗效并评价其成本-效果比。方法将70例慢性阻塞性肺疾病患者随机分为治疗组(给予普米克令舒联合万托林、爱全乐雾化吸入)与对照组(给予万托林、爱全乐联合雾化吸入),运用药物经济学方法进行成本-效果分析。结果治疗组与对照组的成本分别为(596·80±322·27)元、(901·77±360·70)元,总有效率分别为86·67%、75·00%(P>0·05),成本-效果比分别为689、1202。结论治疗组方案较优。
OBJECTIVE： To assess the efficacy and the cost - effectiveness ratios of pulmicort respules in combination of atomized inhalation of ventolin and atrovent on chronic obstructive pulmonary disease （COPD）. METHODS： 70 patients with COPD were randomly assigned to receive pulmicort respules in combination of atomized inhalation of ventolin and atrovent （treatment group） or atomized inhalation of ventolin and atrovent （control group） . The cost- effectiveness analysis was performed employing pharmacoeconomic method. RESULTS： The total costs of treatment group and control group were （596.80±322.27） yuanand （901.77±360.70） yuan, respectively; the total effective rates were 86.67% and 75.00% （P〉 0.05）, respectively and the cost- effectiveness ratios were 689 and 1 202 respectively. CONCLUSION： The treatment group was superior to as compared with the control group.
出处
《中国药房》
CAS
CSCD
北大核心
2006年第22期1715-1717,共3页
China Pharmacy
关键词
普米克令舒
万托林
爱全乐
慢性阻塞性肺疾病
成本-效果分析
analysis Pulmicort respules
Ventolin
Atrovcnt
Chronic obstructive pulmonary disease （COPD）
Cost effectiveness
